Drug Profile
Testosterone transdermal (FemTestosterone TDS) - Labtec
Alternative Names: FemTestosterone TDSLatest Information Update: 13 Nov 2021
Price :
$50
*
At a glance
- Originator Labtec
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Female sexual dysfunction; Menopausal syndrome
Most Recent Events
- 11 May 2006 Discontinued - Preclinical for Female sexual dysfunction in Europe (Transdermal)
- 11 May 2006 Discontinued - Preclinical for Menopausal syndrome in Europe (Transdermal)
- 07 Sep 2000 This product is available for licensing (http://www.labtec-pharma.com)